Marcolin Reports Stable Revenue for First Half of 2025

Published on July 31, 2025
LONGARONE and MILAN, Italy—Marcolin has announced its first half financial results, reporting net sales of €295.7 million, a decrease of 0.6 percent at current exchange rates, but an increase of 0.3 percent at constant exchange rates, compared with the same period last year. Adjusted EBITDA reached €52.3 million (17.7 percent on net sales), the company advised, noting that the result was in line with the previous year despite a “current macroeconomic environment influenced by geopolitical and commercial complexities.” The company’s board of directors approved the consolidated financial results as of June 30, 2025.
Continue reading on website
Other news

Exonate plans to initiate phase 2b CLEAR-DE trial for EXN407 topical formulation for NPDR

July 30, 2025
The first-in-class, twice-daily topical formulation is intended for the treatment of non-proliferative diabetic retinopathy and diabetic macular edema.

A case of orthokeratology for high myopia

July 31, 2025
Paul Levine, OD, FAAO, FIAOMC, details a pediatric case of high myopia in which the patient's prescription had increased from –5.75 DS OU to OD –7.00 DS, OS –6.75 DS within a year.